Take-home-message
JAMA Internal Medicine: Published on May, 2023Diabetic kidney disease is the leading cause of chronic
kidney disease and end-stage kidney failure in the vast majority of the
world. TAKE-HOME MESSAGEThis randomized clinical trial evaluated the use of
glucose-lowering medications on kidney outcomes. A total of 5047 patients with type 2 diabet...
PubMed: Published on April 2022Seborrheic dermatitis (SD) is a
common inflammatory skin disease, which is particularly prevalent in older
adults, presenting with papulosquamous morphology in areas rich in sebaceous
glands, particularly the scalp, face, and body folds.PathogenesisWhile a specific cause of
seborrheic dermatitis remains largely un...
AHA Journals (Circulation): Published on November, 2022Once patients have completed their
dual antiplatelet therapy, we need to stop one of the medications — which one
— ASA or clopidogrel? For many of us, we will keep the ASA and get rid of
the other agent like clopidogrel.This study in Korea included 5438
patients who had PCI with drug-elutin...
Onychomycosis is accounting for up to 50% all nail disorders. It causes not only physical but also psychosocial
and emotional distress to the patient. Treatment of the disease is far from
satisfactory mainly due to high cost and long duration of therapy with poor
patient compliance.TAKE HOME MESSAGE:This
study aims to compare the efficacy of pu...
AACE Endocrine Practice Journal: Published
on May, 2022Nonalcoholic fatty liver disease
(NAFLD) is the most common cause of chronic liver disease affecting 25% of the
global population. NAFLD is associated with
cardiometabolic disorders: (1) obesity, (2) insulin resistance, (3) type 2
diabetes mellitus, (4) high blood pressure, and (5) at...
Indian Journal of Dermatology, Venereology, and Leprology: Published on
2019A 28-year-old man, undergoing
treatment for vitiligo, presented with complaints of new lesions on the neck
for the last 1 week. On examination, multiple hypopigmented macules were seen
on the neck.Figure 1: Patient with vitiligo (red arrow) showing
multiple hypopigment...
The Lancet Diabetes & Endocrinology: Published on
February, 2023Metformin is increasingly being
used during pregnancy, with potentially adverse long-term effects on children. This study aimed to examine
adiposity in children of women with type 2 diabetes from the Metformin in Women
with Type 2 Diabetes in Pregnancy (MiTy) trial, with and withou...
The Lancet: Published on January, 2023The appropriate duration of
postoperative antibiotics for complex appendicitis is unclear. The increasing
global threat of antimicrobial resistance warrants restrictive antibiotic use,
which could also reduce side-effects, length of hospital stay, and costs.TAKE-HOME MESSAGEThis pragmatic, open-label,
rando...
AHA Journal: Stroke: A Journal of Cerebral Circulation: Published on June, 2022Millions of women worldwide use
exogenous hormones as oral contraceptives or hormone replacement therapy.
Still, time-dependent and long-term consequences of exogenous hormones on
stroke risk remains unclear.TAKE-HOME MESSAGEIn this UK Biobank analysis
including 257,...
DIMS PREMIUMWhat are the DIMS Premium Features? RemoveGuidelines: 130 National & International Clinical GuidelinesManagement of Diseases: Quick Diagnosis and Management of 500 DiseasesDrug Details: 2000+ Up-to-date
Drug Information with interactive featuresInvestigation Availability: Investigation’s provider names and
locationsPrescription Writin...
The LANCET: Published on
December, 2022Oral
antivirals have been an important addition to efforts to minimise adverse
COVID-19 outcomes in individuals at high risk.The earlier first
trial of molnupiravir showed only a 30% reduction of hospitalisations and
deaths with molnupiravir compared with placebo. Subsequent observational
studies in...
JAMA Network: Published on April, 2022CVD remains a leading cause of morbidity and mortality
globally. Prevention strategies must address all aspects of a patient’s
lifestyle habits, including healthy nutrition, physical activity, smoking
cessation, and stress reduction. When an individual’s risk is sufficiently
high, pharmacologic therapy is o...
